ALPP (Alkaline Phosphatase, Placental), also known as PLAP, is a well-characterized oncofetal antigen. It is normally expressed in the placenta during pregnancy but is significantly silenced in most healthy adult tissues. Its pathophysiological importance arises from its frequent re-expression in various malignancies, most notably in seminomas and non-seminomatous germ cell tumors, as well as in specific subtypes of ovarian, cervical, and lung cancers. This tumor-restricted expression profile has established ALPP as a classic serum biomarker for diagnosing and monitoring germ cell tumors. Furthermore, its prominent cell-surface localization makes it a compelling and actively investigated target for antibody-based therapeutic modalities, including antibody-drug conjugates (ADCs) and CAR-T cell strategies, aiming to selectively target cancer cells.